ATE357220T1 - Pharmazeutische zusammensetzung mit modifizierter freisetzung - Google Patents

Pharmazeutische zusammensetzung mit modifizierter freisetzung

Info

Publication number
ATE357220T1
ATE357220T1 AT03701497T AT03701497T ATE357220T1 AT E357220 T1 ATE357220 T1 AT E357220T1 AT 03701497 T AT03701497 T AT 03701497T AT 03701497 T AT03701497 T AT 03701497T AT E357220 T1 ATE357220 T1 AT E357220T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
modified release
release pharmaceutical
fraction
allows
Prior art date
Application number
AT03701497T
Other languages
English (en)
Inventor
Monique Berwaer
Michel Deleers
Domenico Fanara
Anthony Guichaux
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Application granted granted Critical
Publication of ATE357220T1 publication Critical patent/ATE357220T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
AT03701497T 2002-01-09 2003-01-08 Pharmazeutische zusammensetzung mit modifizierter freisetzung ATE357220T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02000521 2002-01-09

Publications (1)

Publication Number Publication Date
ATE357220T1 true ATE357220T1 (de) 2007-04-15

Family

ID=8185210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03701497T ATE357220T1 (de) 2002-01-09 2003-01-08 Pharmazeutische zusammensetzung mit modifizierter freisetzung

Country Status (8)

Country Link
US (1) US20050171119A1 (de)
EP (1) EP1465607B1 (de)
JP (1) JP2005519053A (de)
AT (1) ATE357220T1 (de)
AU (1) AU2003202550A1 (de)
DE (1) DE60312642T2 (de)
ES (1) ES2285088T3 (de)
WO (1) WO2003057198A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MEP3608A (en) * 2003-08-08 2011-05-10 Biovail Lab Int Srl Modified-release tablet of bupropion hydrochloride
ES2425762T3 (es) * 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
JP2011140510A (ja) * 2011-03-17 2011-07-21 Biovail Lab Inc 塩酸ブプロピオンの放出調節錠剤
JP6184903B2 (ja) * 2014-06-04 2017-08-23 ヴァレアント インターナショナル バミューダＶａｌｅａｎｔ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｂｅｒｍｕｄａ 塩酸ブプロピオン放出調節錠剤
US11819482B2 (en) 2017-08-29 2023-11-21 Conrig Pharma Aps Composition comprising suplatast tosilate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
US4464376A (en) * 1982-07-22 1984-08-07 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
US4966147A (en) * 1989-04-24 1990-10-30 Eitan Yaniv Method for the diagnosis of allergic rhinitis
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
US6274168B1 (en) * 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
EP1118321A1 (de) * 2000-01-14 2001-07-25 Ucb, S.A. Feste pharmazeutische Zusammensetzungen für die kontrollierte Freisetzung von aktiven Substanzen

Also Published As

Publication number Publication date
JP2005519053A (ja) 2005-06-30
AU2003202550A1 (en) 2003-07-24
DE60312642T2 (de) 2007-11-29
DE60312642D1 (de) 2007-05-03
EP1465607B1 (de) 2007-03-21
WO2003057198A1 (fr) 2003-07-17
ES2285088T3 (es) 2007-11-16
US20050171119A1 (en) 2005-08-04
EP1465607A1 (de) 2004-10-13

Similar Documents

Publication Publication Date Title
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
ATE458486T1 (de) Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
ATE372765T1 (de) Feste pharmazeutische formulierungen mit telmisartan
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
EA200601759A1 (ru) Композиции рамиприла
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
NO20064808L (no) Orale matrixformuleringer med licarbazepin
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
ATE399537T1 (de) Pharmazeutische zusammensetzungen mit atorvastatin, hergestellt ohne granulation
AR066924A1 (es) Formulacion de nevirapina de liberacion prolongada
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
BR0112847A (pt) Uso de uma forma de dosagem sólida
ATE327759T1 (de) Pharmazeutische zusammensetzung mit verlungerter freisetzung
NO20064783L (no) Opplosningstabeletter med licarbazepin
ATE402706T1 (de) Im mund zerfallende pharmazeutische zusammensetzung mit risperidon
DE60310526D1 (de) Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties